Waters Total Liabilities 2010-2025 | WAT
Waters total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Waters total liabilities for the quarter ending June 30, 2025 were $2.558B, a 15.77% decline year-over-year.
- Waters total liabilities for 2024 were $2.725B, a 21.61% decline from 2023.
- Waters total liabilities for 2023 were $3.477B, a 25.19% increase from 2022.
- Waters total liabilities for 2022 were $2.777B, a 1.82% increase from 2021.
| Waters Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $2,725 |
| 2023 | $3,477 |
| 2022 | $2,777 |
| 2021 | $2,727 |
| 2020 | $2,608 |
| 2019 | $2,773 |
| 2018 | $2,160 |
| 2017 | $3,091 |
| 2016 | $2,360 |
| 2015 | $2,210 |
| 2014 | $1,980 |
| 2013 | $1,819 |
| 2012 | $1,701 |
| 2011 | $1,497 |
| 2010 | $1,259 |
| 2009 | $1,059 |
| Waters Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $2,558 |
| 2025-03-31 | $2,629 |
| 2024-12-31 | $2,725 |
| 2024-09-30 | $2,909 |
| 2024-06-30 | $3,037 |
| 2024-03-31 | $3,252 |
| 2023-12-31 | $3,477 |
| 2023-09-30 | $3,592 |
| 2023-06-30 | $3,777 |
| 2023-03-31 | $2,707 |
| 2022-12-31 | $2,777 |
| 2022-09-30 | $2,685 |
| 2022-06-30 | $2,648 |
| 2022-03-31 | $2,666 |
| 2021-12-31 | $2,727 |
| 2021-09-30 | $2,821 |
| 2021-06-30 | $2,835 |
| 2021-03-31 | $2,981 |
| 2020-12-31 | $2,608 |
| 2020-09-30 | $2,721 |
| 2020-06-30 | $2,840 |
| 2020-03-31 | $3,005 |
| 2019-12-31 | $2,773 |
| 2019-09-30 | $2,446 |
| 2019-06-30 | $2,267 |
| 2019-03-31 | $2,282 |
| 2018-12-31 | $2,160 |
| 2018-09-30 | $2,167 |
| 2018-06-30 | $2,183 |
| 2018-03-31 | $2,375 |
| 2017-12-31 | $3,091 |
| 2017-09-30 | $2,534 |
| 2017-06-30 | $2,478 |
| 2017-03-31 | $2,416 |
| 2016-12-31 | $2,360 |
| 2016-09-30 | $2,318 |
| 2016-06-30 | $2,299 |
| 2016-03-31 | $2,267 |
| 2015-12-31 | $2,210 |
| 2015-09-30 | $2,153 |
| 2015-06-30 | $2,096 |
| 2015-03-31 | $2,010 |
| 2014-12-31 | $1,980 |
| 2014-09-30 | $1,910 |
| 2014-06-30 | $1,884 |
| 2014-03-31 | $1,830 |
| 2013-12-31 | $1,819 |
| 2013-09-30 | $1,807 |
| 2013-06-30 | $1,765 |
| 2013-03-31 | $1,731 |
| 2012-12-31 | $1,701 |
| 2012-09-30 | $1,667 |
| 2012-06-30 | $1,621 |
| 2012-03-31 | $1,552 |
| 2011-12-31 | $1,497 |
| 2011-09-30 | $1,481 |
| 2011-06-30 | $1,346 |
| 2011-03-31 | $1,296 |
| 2010-12-31 | $1,259 |
| 2010-09-30 | $1,282 |
| 2010-06-30 | $1,223 |
| 2010-03-31 | $1,168 |
| 2009-12-31 | $1,059 |
| 2009-09-30 | $1,105 |
| 2009-06-30 | $1,072 |
| 2009-03-31 | $1,009 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.722B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.160B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $171.782B | 71.20 |
| IDEXX Laboratories (IDXX) | United States | $50.940B | 53.01 |
| Edwards Lifesciences (EW) | United States | $46.340B | 30.71 |
| Alcon (ALC) | Switzerland | $44.451B | 29.84 |
| IQVIA Holdings (IQV) | United States | $32.700B | 18.48 |
| DexCom (DXCM) | United States | $31.725B | 47.59 |
| Mettler-Toledo (MTD) | United States | $27.244B | 32.34 |
| STERIS (STE) | Ireland | $24.388B | 25.96 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.000B | 0.00 |
| Hologic (HOLX) | United States | $15.084B | 16.34 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.416B | 26.74 |
| Globus Medical (GMED) | United States | $8.261B | 19.06 |
| Masimo (MASI) | United States | $7.973B | 26.83 |
| Teleflex (TFX) | United States | $5.493B | 8.87 |
| Glaukos (GKOS) | United States | $5.221B | 0.00 |
| TransMedics (TMDX) | United States | $4.182B | 63.56 |
| Integer Holdings (ITGR) | United States | $3.723B | 18.58 |
| LivaNova (LIVN) | United Kingdom | $2.920B | 16.71 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| Veracyte (VCYT) | United States | $2.326B | 32.14 |
| PROCEPT BioRobotics (PRCT) | United States | $2.210B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.118B | 25.29 |
| Artivion (AORT) | United States | $1.983B | 100.05 |
| Elekta AB (EKTAY) | Sweden | $1.850B | 17.30 |
| Integra LifeSciences Holdings (IART) | United States | $1.145B | 6.56 |
| OPKO Health (OPK) | United States | $1.080B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.067B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.21 |
| Tandem Diabetes Care (TNDM) | United States | $0.736B | 0.00 |
| AxoGen (AXGN) | United States | $0.707B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.690B | 0.00 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.530B | 9.37 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.472B | 3.79 |
| Treace Medical Concepts (TMCI) | United States | $0.454B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.386B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.369B | 88.00 |
| RxSight (RXST) | United States | $0.360B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.287B | 19.78 |
| NeuroPace (NPCE) | United States | $0.273B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.229B | 0.00 |
| Neuronetics (STIM) | United States | $0.223B | 0.00 |
| 908 Devices (MASS) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Inogen (INGN) | United States | $0.203B | 0.00 |
| CVRx (CVRX) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.170B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.132B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.108B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.081B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.075B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 22.67 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.22 |